TNDM - Tandem Diabetes Care, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.52B
Enterprise Value 33.34B
Trailing P/E N/A
Forward P/E 1-1,000.42
PEG Ratio (5 yr expected) 1-1.65
Price/Sales (ttm)12.50
Price/Book (mrq)24.19
Enterprise Value/Revenue 311.85
Enterprise Value/EBITDA 6-150.71

Trading Information

Stock Price History

Beta (3Y Monthly) -0.13
52-Week Change 363.40%
S&P500 52-Week Change 31.11%
52 Week High 374.81
52 Week Low 326.40
50-Day Moving Average 363.02
200-Day Moving Average 362.27

Share Statistics

Avg Vol (3 month) 31.36M
Avg Vol (10 day) 31.13M
Shares Outstanding 558M
Float 56.02M
% Held by Insiders 15.14%
% Held by Institutions 189.89%
Shares Short (Jul 31, 2019) 43.62M
Short Ratio (Jul 31, 2019) 43.62
Short % of Float (Jul 31, 2019) 47.41%
Short % of Shares Outstanding (Jul 31, 2019) 46.18%
Shares Short (prior month Jun 28, 2019) 43.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Oct 10, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -19.55%
Operating Margin (ttm)-9.94%

Management Effectiveness

Return on Assets (ttm)-8.48%
Return on Equity (ttm)-64.27%

Income Statement

Revenue (ttm)281.71M
Revenue Per Share (ttm)4.91
Quarterly Revenue Growth (yoy)173.30%
Gross Profit (ttm)89.82M
EBITDA -22.14M
Net Income Avi to Common (ttm)-55.06M
Diluted EPS (ttm)-0.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)131.39M
Total Cash Per Share (mrq)2.24
Total Debt (mrq)21.95M
Total Debt/Equity (mrq)15.10
Current Ratio (mrq)2.53
Book Value Per Share (mrq)2.48

Cash Flow Statement

Operating Cash Flow (ttm)10.12M
Levered Free Cash Flow (ttm)16.18M